International Flavors & Fragrances (NYSE:IFF) shares rose around 2% pre-market today after the company reported mixed third-quarter results, with a slight earnings miss offset by a revenue beat that led the company to raise its full-year outlook. Adjusted earnings per share came in at $1.04, just below analyst estimates of $1.07, while revenue reached $2.93 billion, exceeding the expected $2.83 billion. In the third quarter, IFF achieved growth across all its segments, with comparable currency-neutral sales increasing 9% year-over-year. The Health & Biosciences and Scent divisions saw double-digit growth, while Nourish and Pharma Solutions posted high single-digit increases. CEO Erik Fyrwald credited the performance to market recovery and a strong focus on meeting customer needs, which bolstered volumes across divisions. Looking forward, the company raised its full-year 2024 revenue guidance to $11.3-$11.4 billion, up from a previous range of $11.1-$11.3 billion, and now anticipates volume growth of 5-6%, higher than the prior forecast of 3-5%.
I nternational Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through Nourish, Scent, Health & Biosciences, and Pharma Solutions segments. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds, and savory solutions and inclusions. It also provides natural food protection ingredients consist of natural antioxidants and anti-microbials as well as beverages, sweets , and dairy products.